(Transformations)
The newsletter and community for Black women who were never told what peptides could do for them.
Take the 2-Minute QuizThereweretimesIwantedtogiveup.ButIkeptgoingbecauseIknewIwasdoingittobethereforthem.
— Charmaine P. · Louisville, KY
(Transformations)
(Community)
I can keep up with my grandkids now. That's the whole thing for me.
Marcia T.
Atlanta, GA
My daughter was becoming a teenager and I was watching from the couch. I'm not watching anymore.
Miranda R.
Houston, TX
I wanted to live long enough to see their weddings. I needed a real path to actually mean it.
Elisha T.
Atlanta, GA
I can keep up with my grandkids now. That's the whole thing for me.
Marcia T.
Atlanta, GA
My daughter was becoming a teenager and I was watching from the couch. I'm not watching anymore.
Miranda R.
Houston, TX
I wanted to live long enough to see their weddings. I needed a real path to actually mean it.
Elisha T.
Atlanta, GA
I hadn't ridden a roller coaster since I was 12. Last summer I did. My kids watched me do it.
Sophia J.
Los Angeles, CA
My doctor never told me any of this existed. Now I don't miss anything.
Denise W.
Dallas, TX
I stopped going to things. I told myself I was busy. I wasn't busy. I just didn't want to be seen.
Adrienne L.
Atlanta, GA
I hadn't ridden a roller coaster since I was 12. Last summer I did. My kids watched me do it.
Sophia J.
Los Angeles, CA
My doctor never told me any of this existed. Now I don't miss anything.
Denise W.
Dallas, TX
I stopped going to things. I told myself I was busy. I wasn't busy. I just didn't want to be seen.
Adrienne L.
Atlanta, GA
(Join Us)
Tell us where you are. We'll connect you with a licensed Brightmeds provider who builds a care plan around your specific body.
Free to start · No spam · Unsubscribe anytime
(FAQ)
Zepbound (tirzepatide) is the first and only dual GIP and GLP-1 receptor agonist approved for weight management — meaning it activates two hormone pathways instead of one. In clinical trials, participants on Zepbound lost an average of 20.2% of their body weight compared to 13.7% on Wegovy over 72 weeks.
First-generation GLP-1s like semaglutide activate a single hormone receptor. Next-generation peptides go further — dual agonists like tirzepatide target two receptors simultaneously, producing meaningfully greater weight loss with a more complete metabolic effect.
The quiz takes two minutes. It asks about your health history, current conditions, and goals. Once complete, we connect you with Brightmeds, a licensed telehealth service that builds a care plan specific to you.
The Peptide Miracles newsletter and community are free. Many GLP-1 medications are covered by insurance when prescribed for qualifying conditions. For self-pay, Zepbound is available starting at $299 per month.
The most common side effects are nausea, fatigue, and digestive changes — most pronounced in the first few weeks. Your Brightmeds provider will review your full health history before recommending anything.
Research shows that white patients are significantly more likely than Black patients to be prescribed GLP-1 medications — despite Black women having the highest eligibility rates. That gap is about access, bias, and a system that was not built with us at the center.
GLP-1 medications have been prescribed for over a decade with an established long-term safety record. Like any long-term medication, they require monitoring — which is exactly what your Brightmeds provider is there for.
A Johns Hopkins meta-analysis in JAMA Internal Medicine reviewed 64 clinical trials. The findings: GLP-1 medications work equally effectively across racial and ethnic groups. Women outperform men on average, losing approximately 11% vs 7% of starting body weight.